Zerbe Robert L.'s most recent trade in Vericel Corp was a trade of 8,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vericel Corp | Robert L. Zerbe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Robert L. Zerbe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 3,200 | 29,795 (0%) | 0% | - | Common Stock | |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 3,200 | 0 | - | - | Restricted Stock Unit | |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2025 | 2,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.05 per share. | 05 Feb 2025 | 2,500 | 29,095 (0%) | 0% | 13.1 | 32,625 | Common Stock |
| Vericel Corp | Robert L. Zerbe | Director | Sale of securities on an exchange or to another person at price $ 62.50 per share. | 05 Feb 2025 | 2,500 | 26,595 (0%) | 0% | 62.5 | 156,250 | Common Stock |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.05 per share. | 22 Nov 2024 | 2,500 | 29,095 (0%) | 0% | 13.1 | 32,625 | Common Stock |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 2,500 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Robert L. Zerbe | Director | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 22 Nov 2024 | 2,500 | 26,595 (0%) | 0% | 60 | 150,000 | Common Stock |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.05 per share. | 11 Nov 2024 | 2,500 | 29,095 (0%) | 0% | 13.1 | 32,625 | Common Stock |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 2,500 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 2,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Robert L. Zerbe | Director | Sale of securities on an exchange or to another person at price $ 57.50 per share. | 11 Nov 2024 | 2,500 | 26,595 (0%) | 0% | 57.5 | 143,750 | Common Stock |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.05 per share. | 11 Nov 2024 | 2,500 | 29,095 (0%) | 0% | 13.1 | 32,625 | Common Stock |
| Vericel Corp | Robert L. Zerbe | Director | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 11 Nov 2024 | 2,500 | 26,595 (0%) | 0% | 55 | 137,500 | Common Stock |
| Vericel Corp | Robert L. Zerbe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 26,595 (0%) | 0% | - | Common Stock | |
| Vericel Corp | Robert L. Zerbe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 0 | - | - | Restricted Stock Unit | |
| Vericel Corp | Robert L. Zerbe | Director | Sale of securities on an exchange or to another person at price $ 51.57 per share. | 27 Mar 2024 | 3,278 | 23,395 (0%) | 0% | 51.6 | 169,046 | Common Stock |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 3,278 | 0 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 27 Mar 2024 | 3,278 | 26,673 (0%) | 0% | 3.7 | 12,260 | Common Stock |
| Vericel Corp | Zerbe L. Robert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 20 Feb 2024 | 722 | 24,117 (0%) | 0% | 3.7 | 2,700 | Common Stock |
| Vericel Corp | Zerbe L. Robert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 722 | 3,278 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Robert Zerbe L. | Director | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 20 Feb 2024 | 722 | 23,395 (0%) | 0% | 50.0 | 36,107 | Common Stock |
| Vericel Corp | Zerbe Robert L. | Director | Sale of securities on an exchange or to another person at price $ 44.22 per share. | 29 Jan 2024 | 2,300 | 23,395 (0%) | 0% | 44.2 | 101,706 | Common Stock |
| Vericel Corp | Zerbe Robert L. | Director | Sale of securities on an exchange or to another person at price $ 44.02 per share. | 25 Jan 2024 | 200 | 25,695 (0%) | 0% | 44.0 | 8,804 | Common Stock |
| Vericel Corp | L. Zerbe Robert | Director | Sale of securities on an exchange or to another person at price $ 42.05 per share. | 22 Jan 2024 | 3,000 | 25,895 (0%) | 0% | 42.1 | 126,150 | Common Stock |
| Vericel Corp | L. Robert Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2024 | 3,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | L. Zerbe Robert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 22 Jan 2024 | 3,000 | 28,895 (0%) | 0% | 4.1 | 12,360 | Common Stock |
| Vericel Corp | Zerbe Robert L. | Director | Sale of securities on an exchange or to another person at price $ 41.39 per share. | 22 Jan 2024 | 2,500 | 28,395 (0%) | 0% | 41.4 | 103,475 | Common Stock |
| Vericel Corp | Zerbe Robert L. | Director | Sale of securities on an exchange or to another person at price $ 42.06 per share. | 22 Jan 2024 | 2,500 | 25,895 (0%) | 0% | 42.1 | 105,150 | Common Stock |
| Vericel Corp | Zerbe L. Robert | Director | Sale of securities on an exchange or to another person at price $ 38.09 per share. | 12 Jan 2024 | 2,200 | 30,895 (0%) | 0% | 38.1 | 83,798 | Common Stock |
| Vericel Corp | Robert L. Zerbe | Director | Sale of securities on an exchange or to another person at price $ 38.84 per share. | 14 Jul 2023 | 1,000 | 33,395 (0%) | 0% | 38.8 | 38,840 | Common Stock |
| Vericel Corp | Robert L. Zerbe | Director | Sale of securities on an exchange or to another person at price $ 36.00 per share. | 22 Jun 2023 | 3,000 | 34,395 (0%) | 0% | 36 | 108,000 | Common Stock |
| Vericel Corp | Robert L. Zerbe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Robert L. Zerbe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 37,395 (0%) | 0% | - | Common Stock | |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 0 | - | - | Restricted Stock Unit | |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 3,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.60 per share. | 01 Mar 2023 | 3,000 | 34,795 (0%) | 0% | 10.6 | 31,800 | Common Stock |
| Vericel Corp | Robert L. Zerbe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 6,500 | 6,500 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Robert L. Zerbe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 2,600 | 2,600 | - | - | Restricted Stock Unit | |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 2,600 | 4,350 (0%) | 0% | - | Common Stock | |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 2,600 | 0 | - | - | Restricted Stock Unit | |
| Vericel Corp | Robert L. Zerbe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 6,500 | 6,500 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Robert L. Zerbe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 2,600 | 2,600 | - | - | Restricted Stock Unit | |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2021 | 1,750 | 1,750 (0%) | 0% | - | Common Stock | |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2021 | 1,750 | 0 | - | - | Restricted Stock Unit | |
| Vericel Corp | Robert L. Zerbe | Director | Sale of securities on an exchange or to another person at price $ 23.55 per share. | 23 Nov 2020 | 17,500 | 31,795 (0%) | 0% | 23.6 | 412,125 | Common Stock |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.76 per share. | 23 Nov 2020 | 15,000 | 49,295 (0%) | 0% | 2.8 | 41,400 | Common Stock |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2020 | 15,000 | 0 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 23 Nov 2020 | 15,000 | 34,295 (0%) | 0% | 3.7 | 56,100 | Common Stock |
| Vericel Corp | Robert L. Zerbe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2020 | 15,000 | 0 | - | - | Stock Option (right to buy) |